Enhanced Occupational Safety
Significantly lowers the risk of occupational exposure to blood-borne infections by maintaining a completely closed fluid pathway during catheter insertion and tubing connection.
MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Self-sealing mechanical valve design engineered to eliminate blood spillage, protect clinicians, and enhance patient safety during venipuncture.
Blood Control Technology (BCT) represents a major advancement in peripheral intravenous (IV) catheter design, developed to overcome the inherent contamination risks of conventional venipuncture. Standard IV cannulation frequently results in blood leakage at the catheter hub upon needle withdrawal, exposing healthcare providers to blood-borne pathogens such as HIV, Hepatitis B (HBV), and Hepatitis C (HCV).
Lars Medicare incorporates an internal, self-sealing mechanical valve into its BCT IV cannula range. When the introducer needle is removed, the valve automatically closes, blocking blood flow from the vessel until a Luer-lock connection or infusion set is attached. This mechanism operates seamlessly without requiring clinicians to manually compress the vein.
Designed for emergency departments, intensive care units, operating rooms, and general wards, BCT IV cannulas deliver measurable safety and economic advantages.
Significantly lowers the risk of occupational exposure to blood-borne infections by maintaining a completely closed fluid pathway during catheter insertion and tubing connection.
Eliminates the physical strain of maintaining venous compression while reaching for intravenous lines, extension sets, or blood collection tubes, optimizing workflow efficiency.
Moulded from high-grade PTFE or Polyurethane (PUR) compounds with radio-opaque stripes for accurate X-ray placement and smooth indwelling performance.
Reduces consumption of sterile gauze, antiseptic wipes, protective underpads, and linen washing costs associated with accidental blood spillage during cannulation.
Our Blood Control Technology is integrated into multiple catheter configurations to meet international clinical protocols and tender requirements.
Safety IV catheter combining passive needle shielding with an automatic blood-control valve for dual-layer clinical protection against sharps injury and blood exposure.
Advanced safety venous access catheter optimized for rapid fluid delivery, smooth insertion force, and reliable zero-spill blood containment.
Third-generation blood control IV catheter engineered for high-turnover emergency and intensive care settings with instant flashback visualization.
Ergonomic blood-control peripheral catheter featuring low insertion resistance, precise placement confirmation, and stable long-term dwell performance.
All sizes strictly follow ISO color-coding standards to ensure immediate identification during clinical procedures.
| Gauge | Color Code | Outer Diameter (mm) | Catheter Length (mm) | Water Flow Rate (ml/min) | Recommended Clinical Application |
|---|---|---|---|---|---|
| 14G | Orange | 2.1 | 45 | 290 | Trauma, rapid blood transfusion, major surgery |
| 16G | Grey | 1.7 | 45 | 180 | Rapid fluid administration, surgical procedures |
| 18G | Green | 1.3 | 45 | 90 | Blood administration, routine IV infusions |
| 20G | Pink | 1.1 | 32 | 60 | Routine intravenous therapy, adult veins |
| 22G | Blue | 0.9 | 25 | 36 | Pediatric care, elderly patients, small veins |
| 24G | Yellow | 0.7 | 19 | 23 | Pediatric, neonatal, delicate vascular access |
Lars Medicare operates an integrated manufacturing facility in Sonepat, India, designed in compliance with international medical device standards. Every stage of BCT catheter production—from raw polymer processing to cleanroom assembly and final sterilisation—is controlled under a certified ISO 13485 quality management system.
We partner with international distributors, hospital supply corporations, and brand owners to deliver custom-manufactured BCT IV catheters.
Answers to technical and commercial queries regarding Blood Control Technology IV Catheters.
BCT utilizes an internal elastomeric valve mechanism housed within the catheter hub. Upon needle withdrawal after successful venipuncture, the valve automatically seals shut, blocking blood outflow until an extension line or Luer accessory is connected.
Yes. By automatically stopping blood leakage at the hub upon needle withdrawal, BCT eliminates the need for clinicians to perform manual vein occlusion, streamlining workflow and maintaining a sterile field.
Lars Medicare BCT IV cannulas are CE marked and manufactured in ISO 13485:2016 certified cleanroom facilities. They comply with ISO 10993 biocompatibility testing, ISO 80369-7 Luer connector requirements, and ethylene oxide sterilisation standards.
Yes. Lars Medicare provides comprehensive OEM and private-label manufacturing, including customized color-coding, gauge assortments, packaging artwork, multilingual Instructions for Use (IFU), and UDI-compliant barcoding.
Our BCT IV catheters carry a validated 5-year shelf life when stored in a cool, dry place away from direct sunlight, maintaining sterile package integrity throughout the storage cycle.
Contact our international export desk for detailed product specifications, batch certificates, sample requests, and competitive OEM pricing for Blood Control Technology IV Catheters.